TP53 and neoplasm: Moreover, according to documented studies, mutated p53 of amyloid oligomers in MDA-MB-231 (commonly serves as a model for TNBC) tumor cells is more common versus in wt p53 (i.e., MCF7) cells, which indicates the prion-like and oncogenic role of mutant p53 in malignant BCs [11,12].